L. Dubuquoy

Type de document

Co-auteur

W. Wahli

B. Desvergne

P. Desreumaux

J. F. Colombel

J. Auwerx

H. Vancraeyneste

B. Sendid

K. Schoonjans

C. Rousseaux

O. Romano

L. Romani

T. Roger

D. Poulain

M. Peuchmaur

S. Nutten

G.C. Naccari

D. Metzger

M.D. Leibowitz

P. Lefebvre

B. Lefebvre

D. Le Roy

T. Jouault

S. Jawhara

A. Farce

W. Englaro

B. Derijard

A. Cortot

L. Choteau

P. Chavatte

P. Chambon

T. Calandra

P. Bulois

Date

Source

Serveur académique Lausannois (3)

Mot-clé

Treatment (3) Mice (3) Colitis (3) acide (2) effet (2) Scores (2) Rates (2) Tallies (2) Ligands (2) Inflammation (2) Expression (2) Animals (2) Receptors (2) Rates (2) administration (1) thérapie (1) test (1) perméabilité (1) agent pathogène (1) organe (1) mutant (1) mortalité (1) modèle (1) blessure (1) gène (1) ADN (1) reconnaissance de formes (1) survie (1) Colonization (1) Mortality (1)

Documents écrit par L. Dubuquoy (3) | parle de L. Dubuquoy (0)

Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination.

L. Choteau et al. (2017)

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.

C. Rousseaux et al. (2005)

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.

P. Desreumaux et al. (2001)